Diagnostics And Consultancy Center Pulmed EOOD
- Address
- lock Available on a paid plan
Immune System Diseases Research
The Diagnostics And Consultancy Center Pulmed EOOD in Plovdiv is involved in clinical trials focused on immune system diseases, especially chronic inducible urticaria, chronic spontaneous urticaria, prurigo nodularis, and cutaneous lupus erythematosus. These studies are designed to assess whether new therapies can better reduce symptoms such as itching, hives, and skin inflammation.
- Testing new treatment options for chronic inducible urticaria and chronic spontaneous urticaria
- Evaluating symptom control in prurigo nodularis
- Assessing therapy effectiveness in cutaneous lupus erythematosus
The research aims to improve day-to-day disease control and expand options for patients with persistent inflammatory skin and allergy-related conditions.
Skin and Connective Tissue Diseases Research
Clinical research at this site also covers skin and connective tissue diseases, with studies in nummular dermatitis, prurigo nodularis, and cutaneous lupus erythematosus. The main purpose is to understand how well emerging treatments can ease skin lesions, reduce discomfort, and improve overall disease severity.
- Studying treatment response in nummular dermatitis
- Measuring improvement in prurigo nodularis symptoms
- Tracking disease activity in cutaneous lupus erythematosus
These trials help evaluate whether newer therapies can provide more effective relief for chronic inflammatory skin disorders.
Virus Diseases and Prevention Studies
The site is participating in research on virus diseases, including influenza virus. This work focuses on prevention, with trials designed to determine whether a vaccine can protect older adults against influenza illness and support better public health outcomes.
- Preventing influenza virus infection in adults
- Evaluating vaccine effectiveness in older populations
- Supporting protection against seasonal flu disease
This area of research is aimed at strengthening infection prevention strategies, particularly for people at higher risk of complications.
Nutritional and Metabolic Diseases and Cardiovascular Research
Clinical trials at Diagnostics And Consultancy Center Pulmed EOOD also include nutritional and metabolic diseases with a strong focus on cardiovascular disease. The studies are intended to test whether new approaches can lower the risk of major heart and blood vessel events and improve long-term cardiovascular health.
- Assessing prevention of cardiovascular disease complications
- Evaluating treatment benefit for heart and blood vessel health
- Studying ways to reduce major adverse cardiovascular events
These trials reflect an interest in finding more effective strategies for people living with conditions that affect metabolism and the cardiovascular system.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Celldex Therapeutics Inc.1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Celldex Therapeutics Inc.3trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Diagnostics And Consultancy Center Pulmed EOOD
lock Showing 1 of 12 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND) | Amgen Inc. | Phase III | Not Recruiting | Oct 2023 | Jun 2026 |
IMP list
lock Showing 1 of 17 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Barzolvolimab | 3 | Unknown | 2022-11-09 | 2026-04-20 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.